Indonesia - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingVaccine Price in Indonesia - 2022
Contents:
- Vaccine Price in Indonesia (CIF) - 2022
- Vaccine Price in Indonesia (FOB) - 2022
- Vaccine Imports in Indonesia
- Vaccine Exports in Indonesia
Vaccine Price in Indonesia (CIF) - 2022
In 2022, the average vaccine import price amounted to $602,811 per ton, which is down by -3.4% against the previous year. Over the period under review, import price indicated pronounced growth from 2012 to 2022: its price increased at an average annual rate of +4.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, vaccine import price increased by +39.0% against 2020 indices. The most prominent rate of growth was recorded in 2021 an increase of 44%. As a result, import price reached the peak level of $623,806 per ton, and then contracted in the following year.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was China ($1,045,136 per ton), while the price for Thailand ($60,464 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+26.3%), while the prices for the other major suppliers experienced mixed trend patterns.
Vaccine Price in Indonesia (FOB) - 2022
In March 2022, the average vaccine export price amounted to $253K per ton, falling by -26.5% against the previous month. Over the period under review, export price indicated a remarkable increase from January 2022 to March 2022: its price increased at an average monthly rate of +9.4% over the last two months. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on March 2022 figures, vaccine export price increased by +19.7% against January 2022 indices. The most prominent rate of growth was recorded in February 2022 when the average export price increased by 63% against the previous month. As a result, the export price attained the peak level of $345K per ton, and then fell rapidly in the following month.
Prices varied noticeably by the country of destination: the country with the highest price was India ($2.6M per ton), while the average price for exports to Kenya ($60,825 per ton) was amongst the lowest.
From January 2022 to March 2022, the most notable rate of growth in terms of prices was recorded for supplies to India (+43.9%), while the prices for the other major destinations experienced more modest paces of growth.
Vaccine Imports in Indonesia
In 2022, purchases abroad of vaccines for human medicine decreased by -4.2% to 242 tons, falling for the second consecutive year after two years of growth. In general, total imports indicated a resilient expansion from 2019 to 2022: its volume increased at an average annual rate of +9.8% over the last three-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by -21.7% against 2020 indices. The most prominent rate of growth was recorded in 2020 when imports increased by 69%. As a result, imports reached the peak of 309 tons. From 2021 to 2022, the growth of imports failed to regain momentum.
In value terms, vaccine imports fell to $146M in 2022. Overall, total imports indicated a strong increase from 2019 to 2022: its value increased at an average annual rate of +17.5% over the last three-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +62.2% against 2019 indices. The most prominent rate of growth was recorded in 2020 with an increase of 49%.
| Import of Vaccine in Indonesia (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| China | 1.5 | 37.0 | 88.2 | 88.6 | 289.4% |
| United States | 2.3 | 2.3 | 12.9 | 12.9 | 77.7% |
| Netherlands | 0.2 | 0.1 | 6.3 | 6.3 | 215.8% |
| Belgium | 14.6 | 19.1 | 3.7 | 3.7 | -36.7% |
| India | 10.2 | 16.0 | 1.6 | 1.6 | -46.1% |
| France | 15.3 | 14.3 | 1.0 | 1.0 | -59.7% |
| Thailand | 0.2 | 0.3 | 0.6 | 0.6 | 44.2% |
| Germany | N/A | N/A | 11.1 | N/A | 0% |
| Others | 45.7 | 44.8 | 32.1 | 31.0 | -12.1% |
| Total | 89.9 | 134 | 158 | 146 | 17.5% |
Top Suppliers of Vaccine to Indonesia in 2022:
- China (84.8 tons)
- United States (41.3 tons)
- India (20.5 tons)
- Belgium (19.0 tons)
- Netherlands (14.9 tons)
- Thailand (10.2 tons)
- France (4.5 tons)
Vaccine Exports in Indonesia
In 2022, approx. 508 tons of vaccines for human medicine were exported from Indonesia; falling by -14.7% compared with 2021 figures. Overall, exports faced a deep reduction. The pace of growth appeared the most rapid in 2021 with an increase of 28% against the previous year.
In value terms, vaccine exports reduced rapidly to $76M in 2022. Over the period under review, exports saw a deep setback. The growth pace was the most rapid in 2021 when exports increased by 48% against the previous year.
| Export of Vaccine in Indonesia (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| India | 59.5 | 31.2 | 40.9 | 35.8 | -15.6% |
| Nigeria | 2.0 | 1.8 | 17.3 | 14.6 | 94.0% |
| Pakistan | 9.6 | 13.6 | 4.7 | 7.6 | -7.5% |
| Afghanistan | 1.3 | 2.1 | 4.5 | 3.8 | 43.0% |
| Egypt | 1.4 | 2.1 | 2.7 | 2.3 | 18.0% |
| Brazil | 0.1 | 0.4 | 2.2 | 1.8 | 162.1% |
| South Africa | 1.6 | 1.3 | 2.0 | 1.7 | 2.0% |
| Thailand | 3.3 | 1.3 | 1.5 | 1.7 | -19.8% |
| Mali | 1.7 | 0.3 | 0.2 | 0.6 | -29.3% |
| Others | 15.5 | 7.3 | 15.0 | 6.3 | -25.9% |
| Total | 96.0 | 61.5 | 91.0 | 76.2 | -7.4% |
Top Export Markets for Vaccine from Indonesia in 2022:
- India (270.1 tons)
- Nigeria (69.1 tons)
- Pakistan (37.3 tons)
- Brazil (20.0 tons)
- South Africa (19.6 tons)
- Afghanistan (15.7 tons)
- Egypt (11.0 tons)
- Thailand (9.1 tons)
- Mali (7.7 tons)
This report provides an in-depth analysis of the vaccine market in Indonesia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
- Indonesia
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Indonesia
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
623
This report provides an in-depth analysis of the vaccine market in Indonesia.
522
This report provides an in-depth analysis of the antisera market in Indonesia.
489
This report provides an in-depth analysis of the biological product market in Indonesia.
424
This report provides an in-depth analysis of the market for human and animal blood in Indonesia.
454
This report provides an in-depth analysis of the veterinary medicine vaccines market in Indonesia.
2850
This report provides an in-depth analysis of the global vaccine market.
2288
This report provides an in-depth analysis of the global antisera market.
560
This report provides an in-depth analysis of the global biological product market.
647
This report provides an in-depth analysis of the global market for human and animal blood.
754
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
597
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
1231
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o
275
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
1157
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
1079
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
1260
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
1267
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
3236
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
505
Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G
239
Explore the top import markets for Biological Products worldwide, including the United States, Germany, Belgium, and more. Discover key statistics and import values in this article.
